Navigation Links
Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
Date:3/17/2009

One of the small regulatory molecules, named microRNA-125b, is a novel regulator of p53, an important protein that safeguards cells against cancers, Singapore and U.S. scientists report in the March 17, 2009 issue of the journal Genes & Development.

The scientists found that during embryonic development, this microRNA keeps the level of p53 low to avoid excessive cell death.

But, if the DNA is damaged, the microRNA level is reduced to allow an increase in p53, which eliminates damaged cells and thus prevents tumor formation.

The research was conducted with zebrafish.

"Interestingly, this microRNA is elevated in many types of human cancers, suggesting that it may contribute to the formation of tumours by suppressing the p53 protein," said Bing Lim, M.D., Ph.D., lead author and senior group leader at the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and Research (A*STAR).

"Hence, our findings have important implications in the diagnosis and treatment of cancers," he added. "The significance of this finding, of course, once again emphasizes the relevance and importance of research linking microRNAs to many subspecialties of human medicine, including cancer and regenerative medicine."

Harvard Medical School's Judy Lieberman, M.D., Ph.D., said, "This important study provides an elegant and beautifully worked out example of the role of microRNAs in master-minding how a cell responds to environmental cues and developmental signals.

"The implication of this study is that these small molecules might be mimicked or antagonized as drugs to treat serious diseases for which no effective treatment exists at present," added Dr. Lieberman, senior investigator at the Immune Disease Institute, and Professor of Pediatrics and Director of the Division of AIDS at Harvard. She is not a co-author of the paper.

Professor of Cell Biology at the Harvard Medical School, Frank McKeon, Ph.D., commented, "This is an elegant use of zebrafish models to uncover how a single microRNA can regulate the p53 tumor suppressor gene. The strength of this regulation suggests that we will hear more about the microRNA-125b in specific human cancers in the near future." Dr. McKeon also is not a co-author of the paper

MicroRNA-125b is a member of the microRNA family of small regulatory molecules that have evolved in nature to regulate tightly the quantity of protein produced by each messenger RNA (mRNA), which generates the group of proteins that determine the unique characteristics of every cell type.

MicroRNAs play complex roles in the simultaneous fine-tuning of many genes in each cell a role not yet well understood by biologists. It is a complicated, delicate balance that can be profoundly disturbed if just a few microRNAs go awry.

Recent research reveals that microRNAs are abundant in the cell, and that they play important roles in development and in many diseases.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related biology news :

1. Type 1 diabetes triggered by lazy regulatory T-cells: McGill researchers
2. Use of nanomaterials in food packaging poses regulatory challenges
3. New regulatory mechanism discovered for cell identify and behavior in forming organs
4. Caltech researchers help unlock the secrets of gene regulatory networks
5. New data suggest jumping genes play a significant role in gene regulatory networks
6. Food counterfeiting, contamination outpace international regulatory systems
7. Memory molecule stores memories in neocortex
8. Clemson scientists shed light on molecules in living cells
9. Model for the assembly of advanced, single-molecule-based electronic components developed at Pitt
10. Botched production of insulin molecule may lead to diabetes
11. New molecules discovered that block cancer cells from modifying cell DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2019)... N.J. and HERCULES, Calif. (PRWEB) , ... November ... ... of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: ... products, today announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) ...
(Date:11/14/2019)... ... November 13, 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... FDA approved clinical trial for stem cell treatment of knee osteoarthritis . The ... as a subsidiary of VetStem Biopharma. , In July of 2019, PSC received ...
(Date:11/12/2019)... ... November 12, 2019 , ... The Arnold and Mabel Beckman ... research institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data ... site for the acquisition of instrumentation, development and maintenance; support for data science ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... (PRWEB) , ... December 03, 2019 , ... A new ... have shown can reduce and even reverse fibrosis (scar tissue) buildup – also improves ... Stanford University School of Medicine, was conducted on mice. , The tumor-destroying capabilities ...
(Date:12/2/2019)... ... December 02, 2019 , ... Registration is now ... Meeting, which will be held at the Hynes Convention Center May 12-15, 2020, in ... therapy and brings together scientists, physicians, patient advocates, and other stakeholders with the goal ...
(Date:11/22/2019)... ... November 21, 2019 , ... Lajollacooks4u is preparing for another busy ... company already scheduled several of its popular cooking classes and team-building events, but the ... The company’s Holiday Parties have been a favorite for companies of all sizes since ...
(Date:11/12/2019)... ... 2019 , ... REPROCELL Inc. a stem cell and drug ... to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. ... unique and genetically edited cell lines from various tumors. The data generated from ...
Breaking Biology Technology: